CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer

Recruiting now

Conditions studied: Cancer, Early Detection of Cancer

In brief

The purpose of the researchers is to test whether the CancerenD24 index, an algorithm based on the quantitative value of CD24, CD11b, clinical and laboratory characteristics, developed in the laboratory can help in the early detection of a malignant disease in a population of healthy subjects.

Key facts

Study ID

NCT06656728

Run by

Tel-Aviv Sourasky Medical Center

People needed

2000

Starts

2024-09-03

Expected to finish

2027-09-01

Last updated by the study team

2024-10-24

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Completion of all medical exams and questionnaires including cancer diagnoses, demographic data and other epidemiologic information
• Willing and able to sign an informed consent
• Age ≥40 years

You may not qualify if…

• Age < 40 years
• Pregnancy or breastfeeding
• Any type of fever
• Any cancer active at study entry or up to 5 years prior to study entry
• Polyposis syndromes
• Inflammatory bowel disease
• Unwilling or unable to provide informed consent

Where it is running

• Integrated Cancer Prevention Center at the Tel Aviv Sourasky Medical Center Ichilov — Tel Aviv, Israel (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.